Wonderful | $34,000,000 | (Jul 4, 2025)
Argon AI | $5,500,000 | (Jul 4, 2025)
The Open Platform | $28,500,000 | (Jul 4, 2025)
oncgnostics GmbH
Germany
- Jena, Thüringen
- 11/09/2023
- Unknown
- Undisclosed Amount
oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics.
- Industry Biotechnology Research
- Website https://www.oncgnostics.com/
- LinkedIn https://www.linkedin.com/company/oncgnostics/about/
Related People
Martina SchmitzFounder
Germany -
Jena, Thuringia
oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics.
First product is our CE IVD marked test "GynTect", a 2nd-line test for reliably detecting cervical cancer.
A short comic (german) explains what GynTect is doing.
On the Seedmatch-platform, there are a lot of insides on our company (german) and two nice videos about our company.
2016: https://www.seedmatch.de/startups/oncgnostics-2
2017: https://www.seedmatch.de/startups/oncgnostics
CIMware | $2,300,000 | (Jul 4, 2025)
FitFeast (As Seen on Shark Tank) | $643,286 | (Jul 4, 2025)
Yaspa | $12,000,000 | (Jul 4, 2025)
Nautica Technologies | $3,999,764 | (Jul 4, 2025)
Luma fertility | $4,000,000 | (Jul 4, 2025)
Circulate | $12,000,000 | (Jul 4, 2025)
AssetCool | $13,648,243 | (Jul 4, 2025)
Vok Bikes | $6,000,000 | (Jul 4, 2025)
MediShout | $9,000,000 | (Jul 4, 2025)